Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W CAMPBELL

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Cardiology|January 1, 1994
Government intervention in cardiovascular disease--help or hindrance? A clinician's viewpointR W Campbell
Drugs|November 1, 1988
Assessment of the risk-benefit ratio for antiarrhythmic drug useR W Campbell
European Heart Journal|April 1, 1994
What happens to people with 'supra' ventricular tachycardia?R W Campbell
Journal of Cardiovascular Pharmacology|January 1, 1991
Predisposing factors for ventricular arrhythmiasR W Campbell
American Heart Journal|December 1, 1980
Placebo controlled study of prophylaxis of ventricular arrhythmias in acute myocardial infarctionR W Campbell
Postgraduate Medical Journal|January 1, 1991
The deficiencies of current medical therapy for the management of angina pectorisR W Campbell
European Heart Journal|July 1, 1996
Supraventricular tachycardia. Occasional nuisance or frequent threat?R W Campbell
Cardiovascular Drugs and Therapy|August 1, 1995
Coadministration of calcium antagonists and ACE inhibitors--is a skeptic convinced?: a personal viewR W Campbell
European Heart Journal|May 1, 1997
Supraventricular tachycardia. Doing the right thingsR W Campbell
European Heart Journal|May 1, 1990
Heart failure--the options for therapyR W Campbell
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Cardiology|January 1, 1994
Government intervention in cardiovascular disease--help or hindrance? A clinician's viewpointR W Campbell
Drugs|November 1, 1988
Assessment of the risk-benefit ratio for antiarrhythmic drug useR W Campbell
European Heart Journal|April 1, 1994
What happens to people with 'supra' ventricular tachycardia?R W Campbell
Journal of Cardiovascular Pharmacology|January 1, 1991
Predisposing factors for ventricular arrhythmiasR W Campbell
American Heart Journal|December 1, 1980
Placebo controlled study of prophylaxis of ventricular arrhythmias in acute myocardial infarctionR W Campbell
Postgraduate Medical Journal|January 1, 1991
The deficiencies of current medical therapy for the management of angina pectorisR W Campbell
European Heart Journal|July 1, 1996
Supraventricular tachycardia. Occasional nuisance or frequent threat?R W Campbell
Cardiovascular Drugs and Therapy|August 1, 1995
Coadministration of calcium antagonists and ACE inhibitors--is a skeptic convinced?: a personal viewR W Campbell
European Heart Journal|May 1, 1997
Supraventricular tachycardia. Doing the right thingsR W Campbell
European Heart Journal|May 1, 1990
Heart failure--the options for therapyR W Campbell
Pageof 12